Patent · US Active

Inhibitors of bruton's tyrosine kinase

US8124604B2 · kind B2 · utility

18Cited by
1References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 10, 2011
Grant dateFeb 28, 2012
Priority date
Expiry dateJan 10, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This application discloses 5-phenyl-1H-pyridin-2-one and 6-phenyl-2H-pyridazin-3-one derivatives according to generic Formulae I-IV:wherein, variables R, X, Y1, Y2, Y2′, Y3, Y4, n and m are defined as described herein, which inhibit Btk. The compounds disclosed herein are useful to modulate the activity of Btk and treat diseases associated with excessive Btk activity. The compounds are further useful to treat inflammatory and auto immune diseases associated with aberrant B-cell proliferation such as rheumatoid arthritis. Also disclosed are compositions comprising compounds of Formulae I-IV and at least one carrier, diluent or excipient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.